🇫🇷
France · FR · FR:66316458
OXLUMO 94,5 mg/0,5mL, solution injectable
ReimbursedATC A16AX
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerALNYLAM NETHERLANDS (PAYS-BAS)
CountryFR (France)
ATC codeA16AX
Dispensing—
ReimbursedYes
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 1
- cip1334009302174431 flacon(s) en verre de 0,5 mlEUR 46.93
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "66316458",
"date_amm": "2020-11-19",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/20/1496",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "sous-cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code A16AX.
- 🇪🇸CERDELGA 84 MG CAPSULAS DURASSanofi B.V.
- 🇫🇷CERDELGA 84 mg, géluleSANOFI (PAYS-BAS)
- 🇺🇸CUVRIOROrphalan SA
- 🇪🇸GIVLAARI 189 MG/ML SOLUCION INYECTABLEAlnylam Netherlands B.V.
- 🇫🇷GIVLAARI 189 mg/mL, solution injectableALNYLAM NETHERLANDS (PAYS-BAS)
- 🇨🇭Iberogast Classic
- 🇨🇭Iberogast Classic
- 🇨🇭Iberogast ClassicBayer (Schweiz) AG
Access this data programmatically
Query OXLUMO 94,5 mg/0,5mL, solution injectable and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.